This study investigated the impact of Automatic Sound Management 3.0 (i.e. ambient noise reduction, transient noise reduction and an adaptive intelligence) as implemented in the SONNET2 on CI users' speech performance and their subjective quality of hearing and device handling.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* A minimum of 18 years old
* Experienced user (≥ 6 months) of a MED-EL cochlear implant (CI; C40+ and later model)
* Experienced user of a MED-EL SONNET audio processor (≥ 6 months)
* Post-lingual onset of bilateral severe to profound sensory-neural hearing loss
* Unilateral CI user
* A minimum of 10 active electrodes
* A minimum of 40% speech recognition in the Freiburg Monosyllables test in quiet at 65 dB sound pressure level (SPL; at the last time tested)
* Fluent in German (the language of the test centre)
* Signed and dated Informed Consent Form before the start of any study-specific procedure.
Exclusion Criteria:
* Lack of compliance with any inclusion criteria
* CI user with contralateral hearing equal to or better than 60 dB (PTA measured at 500, 1000, and 2000Hz)
* User with electric-acoustic stimulation (EAS; user of an EAS audio processor)
* Implanted with C40X and C40C
* Implanted with an Auditory Brainstem Implant or Split electrode array
* Known allergic reactions to components of the investigational medical device
* Unstable psychological status
* Anything that, in the opinion of the Investigator, would place the subject at increased risk or preclude the subject's full compliance with or completion of the study